These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 9459395)

  • 21. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles virus genotyping an important tool in measles outbreak investigation in Norway, 2011.
    Vainio K; Steen TW; Arnesen TM; Rønning K; Ånestad G; Dudman S
    Euro Surveill; 2012 Dec; 17(50):. PubMed ID: 23241234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors contributing to measles transmission during an outbreak in Kamwenge District, Western Uganda, April to August 2015.
    Nsubuga F; Bulage L; Ampeire I; Matovu JKB; Kasasa S; Tanifum P; Riolexus AA; Zhu BP
    BMC Infect Dis; 2018 Jan; 18(1):21. PubMed ID: 29310585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa.
    Whittle HC; Aaby P; Samb B; Jensen H; Bennett J; Simondon F
    Lancet; 1999 Jan; 353(9147):98-102. PubMed ID: 10023894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects.
    Whittle H; Hanlon P; O'Neill K; Hanlon L; Marsh V; Jupp E; Aaby P
    Lancet; 1988 Oct; 2(8615):811-4. PubMed ID: 2902264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine-modified measles in previously immunized children in Accra, Ghana: clinical, virological and serological parameters.
    Ishiwada N; Addae MM; Tetteh JK; Yempewu SM; Ofori-Adjei D; Kamiya H; Akanmori BD
    Trop Med Int Health; 2001 Sep; 6(9):694-8. PubMed ID: 11555436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles: summary of worldwide impact.
    Assaad F
    Rev Infect Dis; 1983; 5(3):452-9. PubMed ID: 6878998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measles immunity and response to revaccination of a young adult population in Israel.
    Mendelson E; Duvdevani P; Varsano N; Lerman Y; Slepon R; Dagan R; Cohen D; Danon Y; Shohat T
    J Med Virol; 1996 Nov; 50(3):249-53. PubMed ID: 8923290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
    Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
    BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serological evidence of persistent elimination of measles in Czechoslovakia].
    Strauss J; Svandová E; Smelhausová M; Mrázová M
    Cas Lek Cesk; 1989 Mar; 128(13):399-403. PubMed ID: 2790867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potency status and efficacy of measles vaccine administered in Nigeria: a case study of three EPI centres in Lagos, Nigeria.
    Omilabu SA; Oyefolu AO; Ojo OO; Audu RA
    Afr J Med Med Sci; 1999; 28(3-4):209-12. PubMed ID: 11205835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of measles hemagglutination inhibiting antibody levels among school children in Ibadan, Nigeria.
    Ogundiji OT; Okonko IO; Adu FD
    J Immunoassay Immunochem; 2013; 34(2):208-17. PubMed ID: 23537304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 35. A measles outbreak in Sindh, Pakistan caused by a genotype B3 virus.
    Zaidi SSZ; Hameed A; Ali N; Umair M; Alam MM; Rana MS; Sharif S; Aamir UB; Shaukat S; Angez M; Khurshid A; Akhtar R; Mehmood N; Badar N
    Arch Virol; 2017 Dec; 162(12):3603-3610. PubMed ID: 28803415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles outbreak in 2019: a warning for the post-COVID-19 pandemic period.
    Salimović-Bešić I; Musa S; Kotorić-Keser Š; Zahirović E; Mutevelić S; Dedeić-Ljubović A
    J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 38995847
    [No Abstract]   [Full Text] [Related]  

  • 37. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles antibody levels in children of rural and urban areas of Nigeria following vaccination campaign.
    Eghafona NO; Odama LE; Emejuaiwe SO; Obineche EN; Tafida DS
    Epidemiol Infect; 1987 Aug; 99(1):85-9. PubMed ID: 3609176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
    Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
    East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative impact of clinical misdiagnosis of measles on health workers' confidence in measles vaccine.
    Helfand RF; Chibi T; Biellik R; Shearley A; Bellini WJ
    Epidemiol Infect; 2004 Jan; 132(1):7-10. PubMed ID: 14979583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.